Trevi Therapeutics Stock Price Prediction

TRVI Stock  USD 3.76  0.02  0.53%   
The relative strength index (RSI) of Trevi Therapeutics' share price is above 70 as of 18th of January 2025. This usually implies that the stock is becoming overbought or overvalued. The idea behind Relative Strength Index (RSI) is that it helps to track how fast people are buying or selling Trevi, making its price go up or down.

Oversold Vs Overbought

70

 
Oversold
 
Overbought
The successful prediction of Trevi Therapeutics' future price could yield a significant profit. We analyze noise-free headlines and recent hype associated with Trevi Therapeutics, which may create opportunities for some arbitrage if properly timed. Below are the key fundamental drivers impacting Trevi Therapeutics' stock price prediction:
EPS Estimate Next Quarter
(0.11)
EPS Estimate Current Year
(0.48)
EPS Estimate Next Year
(0.48)
Wall Street Target Price
9.9444
EPS Estimate Current Quarter
(0.12)
Using Trevi Therapeutics hype-based prediction, you can estimate the value of Trevi Therapeutics from the perspective of Trevi Therapeutics response to recently generated media hype and the effects of current headlines on its competitors. We also analyze overall investor sentiment towards Trevi Therapeutics using Trevi Therapeutics' stock options and short interest. It helps to benchmark the overall future attitude of investors towards Trevi using crowd psychology based on the activity and movement of Trevi Therapeutics' stock price.

Trevi Therapeutics Implied Volatility

    
  1.71  
Trevi Therapeutics' implied volatility exposes the market's sentiment of Trevi Therapeutics stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Trevi Therapeutics' implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Trevi Therapeutics stock will not fluctuate a lot when Trevi Therapeutics' options are near their expiration.
The fear of missing out, i.e., FOMO, can cause potential investors in Trevi Therapeutics to buy its stock at a price that has no basis in reality. In that case, they are not buying Trevi because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.

Trevi Therapeutics after-hype prediction price

    
  USD 3.76  
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.

Prediction based on Rule 16 of the current Trevi contract

Based on the Rule 16, the options market is currently suggesting that Trevi Therapeutics will have an average daily up or down price movement of about 0.11% per day over the life of the 2025-04-17 option contract. With Trevi Therapeutics trading at USD 3.76, that is roughly USD 0.004018 . If you think that the market is fully incorporating Trevi Therapeutics' daily price movement you should consider acquiring Trevi Therapeutics options at the current volatility level of 1.71%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
  
Check out Trevi Therapeutics Basic Forecasting Models to cross-verify your projections.
For more detail on how to invest in Trevi Stock please use our How to Invest in Trevi Therapeutics guide.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Trevi Therapeutics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Intrinsic
Valuation
LowRealHigh
0.153.0710.16
Details
9 Analysts
Consensus
LowTargetHigh
9.059.9411.04
Details
Earnings
Estimates (0)
LowProjected EPSHigh
-0.13-0.12-0.11
Details

Trevi Therapeutics After-Hype Price Prediction Density Analysis

As far as predicting the price of Trevi Therapeutics at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Trevi Therapeutics or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Trevi Therapeutics, with the unreliable approximations that try to describe financial returns.
   Next price density   
       Expected price to next headline  

Trevi Therapeutics Estimiated After-Hype Price Volatility

In the context of predicting Trevi Therapeutics' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Trevi Therapeutics' historical news coverage. Trevi Therapeutics' after-hype downside and upside margins for the prediction period are 0.19 and 10.85, respectively. We have considered Trevi Therapeutics' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
3.76
3.76
After-hype Price
10.85
Upside
Trevi Therapeutics is very risky at this time. Analysis and calculation of next after-hype price of Trevi Therapeutics is based on 3 months time horizon.

Trevi Therapeutics Stock Price Prediction Analysis

Have you ever been surprised when a price of a Company such as Trevi Therapeutics is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Trevi Therapeutics backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Trevi Therapeutics, there might be something going there, and it might present an excellent short sale opportunity.
Expected ReturnPeriod VolatilityHype ElasticityRelated ElasticityNews DensityRelated DensityExpected Hype
  0.40 
7.09
  0.09 
 0.00  
8 Events / Month
13 Events / Month
In about 8 days
Latest traded priceExpected after-news pricePotential return on next major newsAverage after-hype volatility
3.76
3.76
0.00 
3,223  
Notes

Trevi Therapeutics Hype Timeline

Trevi Therapeutics is at this time traded for 3.76. The entity has historical hype elasticity of 0.09, and average elasticity to hype of competition of 0.0. Trevi is anticipated not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is over 100%. The immediate return on the next news is anticipated to be very small, whereas the daily expected return is at this time at 0.4%. %. The volatility of related hype on Trevi Therapeutics is about 72629.27%, with the expected price after the next announcement by competition of 3.76. About 70.0% of the company shares are owned by institutional investors. The company recorded a loss per share of 0.44. Trevi Therapeutics had not issued any dividends in recent years. Given the investment horizon of 90 days the next anticipated press release will be in about 8 days.
Check out Trevi Therapeutics Basic Forecasting Models to cross-verify your projections.
For more detail on how to invest in Trevi Stock please use our How to Invest in Trevi Therapeutics guide.

Trevi Therapeutics Related Hype Analysis

Having access to credible news sources related to Trevi Therapeutics' direct competition is more important than ever and may enhance your ability to predict Trevi Therapeutics' future price movements. Getting to know how Trevi Therapeutics' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Trevi Therapeutics may potentially react to the hype associated with one of its peers.
Hype
Elasticity
News
Density
Semi
Deviation
Information
Ratio
Potential
Upside
Value
At Risk
Maximum
Drawdown
LIFELIFE Old 0.03 1 per month 2.62  0.09  6.45 (5.29) 28.98 
CUECue Biopharma 0.04 9 per month 6.43  0.05  20.27 (11.26) 55.51 
ANTXAN2 Therapeutics(0.03)12 per month 2.56  0.07  8.94 (4.72) 28.89 
BCABBioatla(0.01)9 per month 0.00 (0.24) 8.85 (11.59) 54.97 
SPROSpero Therapeutics 0.03 9 per month 0.00 (0.12) 5.56 (4.76) 17.35 
BOLTBolt Biotherapeutics(0.01)8 per month 0.00 (0.09) 5.00 (6.45) 16.07 
CHRSCoherus BioSciences 0.05 9 per month 4.22  0.11  13.89 (8.00) 45.84 
GRCLGracell Biotechnologies 0.00 0 per month 6.35  0.17  16.34 (6.25) 52.11 
NLTXNeoleukin Therapeutics(0.14)1 per month 0.00 (0.05) 4.05 (3.53) 27.84 
FHTXFoghorn Therapeutics(0.24)7 per month 0.00 (0.18) 5.05 (8.30) 20.44 
CCCCC4 Therapeutics(0.70)9 per month 0.00 (0.09) 9.28 (8.28) 24.60 
CYTCyteir Therapeutics 0.09 2 per month 2.57  0.1  10.00 (5.26) 36.14 
PRLDPrelude Therapeutics 0.01 8 per month 0.00 (0.09) 11.20 (9.09) 55.77 
RZLTRezolute(0.08)7 per month 3.31  0.02  6.80 (5.95) 19.56 
LYRALyra Therapeutics(0.02)5 per month 6.06 (0) 10.53 (10.00) 40.57 
SQZSqz Biotechnologies Co 0.53 1 per month 0.00 (0.14) 5.26 (23.08) 103.87 
TARAProtara Therapeutics 0.25 10 per month 4.14  0.17  13.00 (7.16) 78.24 
SEERSeer Inc 0.20 5 per month 2.23  0.08  6.01 (4.04) 13.13 
ORICOric Pharmaceuticals 0.22 11 per month 4.61  0.02  8.04 (6.91) 22.87 
ANEBAnebulo Pharmaceuticals(0.02)6 per month 6.01  0.0002  7.64 (10.43) 40.03 
CGEMCullinan Oncology LLC(0.41)9 per month 0.00 (0.18) 5.13 (7.10) 17.85 

Trevi Therapeutics Additional Predictive Modules

Most predictive techniques to examine Trevi price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Trevi using various technical indicators. When you analyze Trevi charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

About Trevi Therapeutics Predictive Indicators

The successful prediction of Trevi Therapeutics stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Trevi Therapeutics, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Trevi Therapeutics based on analysis of Trevi Therapeutics hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Trevi Therapeutics's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Trevi Therapeutics's related companies.
 2024 2025 (projected)
Payables Turnover0.06120.0643
Days Of Inventory On Hand8.0K7.6K

Story Coverage note for Trevi Therapeutics

The number of cover stories for Trevi Therapeutics depends on current market conditions and Trevi Therapeutics' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Trevi Therapeutics is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Trevi Therapeutics' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.

Trevi Therapeutics Short Properties

Trevi Therapeutics' future price predictability will typically decrease when Trevi Therapeutics' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Trevi Therapeutics often depends not only on the future outlook of the potential Trevi Therapeutics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Trevi Therapeutics' indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding99 M
Cash And Short Term Investments83 M

Complementary Tools for Trevi Stock analysis

When running Trevi Therapeutics' price analysis, check to measure Trevi Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Trevi Therapeutics is operating at the current time. Most of Trevi Therapeutics' value examination focuses on studying past and present price action to predict the probability of Trevi Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Trevi Therapeutics' price. Additionally, you may evaluate how the addition of Trevi Therapeutics to your portfolios can decrease your overall portfolio volatility.
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account